Latest Posts

Company Profile

Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.

BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow.

Read More

Science & Technology

Ischemic Stroke Stroke is the leading cause of adult long-term disability and the third leading cause of death in the U.S. An estimated
Read More >
The SPG BrainsGate technology is based on established scientific evidence that electrical stimulation of the Spheno-Palatine Gan
Read More >
ISS A novel peptide developed for the treatment of Cognitive Impairment
Read More >